All Posts

In my time leading the Life Sciences Practice Area at Fletcher, I’ve seen just how vastly differently organizations choose to anchor their CI efforts. Some operate absent a formal CI function at all, while others are in the infancy stages of a more formidable buildout. And then there are the companies that have made substantive investments altogether, standing up full departments and giving CI a real seat at the executive table.

In this volatile and increasingly uncertain world, there has never been a better time to stress-test the intelligence capabilities of any organisation, irrespective of market sector and size. Most companies discovered their supply chain vulnerabilities the hard way — through disruption. The same pattern is now playing out with geopolitical risk. The window to get ahead of it is closing fast.

Health insurance has always been a margin-sensitive industry. In the past, carriers could often differentiate through value-added wellness programs, large-scale marketing campaigns, and expanded benefit offerings. While those elements still play a role, the market has fundamentally shifted. Today, the U.S. health insurance industry is increasingly defined by cost pressure and margin management, as carriers struggle to balance rising healthcare expenses against...